BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 16564043)

  • 1. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
    Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y
    Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform.
    Sugimoto N; Takuwa N; Okamoto H; Sakurada S; Takuwa Y
    Mol Cell Biol; 2003 Mar; 23(5):1534-45. PubMed ID: 12588974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase.
    Takashima S; Sugimoto N; Takuwa N; Okamoto Y; Yoshioka K; Takamura M; Takata S; Kaneko S; Takuwa Y
    Cardiovasc Res; 2008 Sep; 79(4):689-97. PubMed ID: 18480127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1.
    Van Leeuwen FN; Olivo C; Grivell S; Giepmans BN; Collard JG; Moolenaar WH
    J Biol Chem; 2003 Jan; 278(1):400-6. PubMed ID: 12393875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.
    Okamoto H; Takuwa N; Yokomizo T; Sugimoto N; Sakurada S; Shigematsu H; Takuwa Y
    Mol Cell Biol; 2000 Dec; 20(24):9247-61. PubMed ID: 11094076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
    Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
    Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
    Olianas MC; Dedoni S; Onali P
    Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho.
    Hilal-Dandan R; Means CK; Gustafsson AB; Morissette MR; Adams JW; Brunton LL; Heller Brown J
    J Mol Cell Cardiol; 2004 Apr; 36(4):481-93. PubMed ID: 15081308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
    Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity.
    Liu F; Verin AD; Wang P; Day R; Wersto RP; Chrest FJ; English DK; Garcia JG
    Am J Respir Cell Mol Biol; 2001 Jun; 24(6):711-9. PubMed ID: 11415936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling.
    Stam JC; Michiels F; van der Kammen RA; Moolenaar WH; Collard JG
    EMBO J; 1998 Jul; 17(14):4066-74. PubMed ID: 9670021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
    Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
    Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.
    Lee M; Choi S; Halldén G; Yo SJ; Schichnes D; Aponte GW
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G641-54. PubMed ID: 19679818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
    Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
    J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells.
    Maddala R; Reddy VN; Epstein DL; Rao V
    Mol Vis; 2003 Jul; 9():329-36. PubMed ID: 12876554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
    Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
    Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes.
    Sato K; Horiuchi Y; Jin Y; Malchinkhuu E; Komachi M; Kondo T; Okajima F
    J Neurochem; 2011 Apr; 117(1):164-74. PubMed ID: 21244430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation.
    Shano S; Hatanaka K; Ninose S; Moriyama R; Tsujiuchi T; Fukushima N
    Biochim Biophys Acta; 2008 May; 1783(5):748-59. PubMed ID: 18157949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
    Lee CW; Rivera R; Dubin AE; Chun J
    J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
    Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
    Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.